NCT00048659终止2 期
YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 试验地点
- 59
研究概览
简要总结
The purpose of this study is to determine if patients who take YM598 in addition to mitoxantrone and prednisone (standard therapy) experience improvement in the pain associated with prostate cancer metastases in the bone.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (59)
Loading locations...
相似试验
终止
2 期
YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate CancerProstate CancerNCT00050297Astellas Pharma Inc
已完成
不适用
Evaluation the effect of adding methylprednisolone to mitoxantrone on progressive multiple sclerosis treatmentMultiple Sclerosis.Demyelinating diseases of the central nervous systemIRCT201107145943N3Yazd University of Medical Sciences70
已完成
不适用
The effect of methylprednisolon plus mitoxantrone in the treatment of progressive multiple sclerosisMultiple sclerosisMultiple sclerosis.IRCT201012245393N1Shahid Sadooghi University of Medical Sciences and Health Services36
Unknown
2 期
Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in CombinationMultiple SclerosisNCT01627938PD Dr. Andrew Chan50
已完成
1 期
AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid LeukemiaLeukemia, Myeloid, AcuteNCT00512252Washington University School of Medicine52